---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-041978"
form_type: "8-K"
ticker: "GCTK"
cik: "0001506983"
company_name: "Glucotrack, Inc."
filed_at: "2026-09-09T21:00:13+00:00"
generated_at: "2026-09-09T21:02:11.165595+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Glucotrack settles Alto debt dispute with $2M cash and $2M convertible note

## Summary
- Settlement with Alto resolves ~$10.9M asserted debt from Apimeds Pharmaceuticals; Glucotrack and others jointly liable.
- Pays $2.0M initial cash, issues $2.0M convertible note (5% interest, quarterly $500k payments from Nov 30, 2026 to Aug 31, 2027), plus up to $125k legal fees.
- Note convertible into GCTK common at $2.98/share, subject to 9.99% beneficial ownership cap and Nasdaq limits.
- Alto's release effective upon full payment; default triggers acceleration and increased interest.

## SEC filing metadata
- accession: 0001493152-26-041978
- form_type: 8-K
- ticker: GCTK
- cik: 0001506983
- company_name: Glucotrack, Inc.
- filed_at: 2026-09-09T21:00:13+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 2.03, 3.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1506983/000149315226041978/0001493152-26-041978-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1506983/000149315226041978/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-041978
- JSON: https://secwatch.observer/filing/0001493152-26-041978.json
- Plain text: https://secwatch.observer/filing/0001493152-26-041978.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.